Differential expression of a novel voltage gated potassium channel Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma

British Journal of Neurosurgery

Volumn 26, Issue 1, 2012, Pages 16-20

  Arvind, S ^a   Arivazhagan, A ^a   Santosh, V ^a   Chandramouli, B A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Astrocytoma; Glioblastoma; Grade specific expression; Immunohistochemistry; Kv1.5 protein expression; Prognosis

Indexed keywords

POTASSIUM CHANNEL KV1.5;

APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN CORTEX; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KV1.5 POTASSIUM CHANNEL; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856599468     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2011.583365     Document Type: Article

References (27)

1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classif cation of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-5.
2. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 1997;3:523-30. (Pubitemid 27211828)
3. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol2007;170:1445-53. (Pubitemid 47339290)
4. Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozyg-osity on 10q25-qter. Am J Pathol 1999;155:387-94. (Pubitemid 29370389)
5. Nakamura M, Ishida E, Shimada K, et al. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. Lab Invest 2005;85:165-75. (Pubitemid 40208920)
6. Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 2010;102:932-41.
7. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005; 205:159-73. (Pubitemid 41803693)
8. Ullrich N, Sontheimer H. Cell cycle-dependent expression of a glioma-specif c chloride current: proposed link to cytoskeletal changes. A m J Physiol1997;273:C1290-7.
9. Wang XT, Nagaba Y, Cross HS, Wrba F, Zhang L, Guggino SE. The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. Am J Pathol 2000;157:1549-62.
10. + conductance. Am J Physiol 1999;276:C1405-10. (Pubitemid 29323406)
11. Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol1996;154:91-107. (Pubitemid 26413993)
12. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stuhmer W. Role of voltage-gated potassium channels in cancer. J Membr Biol 2005;205(3):115-24. (Pubitemid 41803688)
13. Lan M, Shi Y, Han Z, et al. Expression of delayed rectif er potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol T er2005;4:1342-7. (Pubitemid 43131178)
14. Bonnet S, Archer SL, lalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007;11:37-51. (Pubitemid 46054520)
15. Preussat K, Beetz C, Schrey M, et al. Expression of voltagegated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 2003;346:33-6. (Pubitemid 36792187)
16. Wickenden A. K(+) channels as therapeutic drug targets. Pharmacol T er2002;94:157-82.
17. Verkhratsky A, Steinhauser C. Ion channels in glial cells. Brain Res Brain Res Rev 2000;32:380-412. (Pubitemid 30171314)
18. MacKinnon R. New insights into the structure and function of potassium channels. Curr Opin Neurobiol 1991;1:14-9.
19. MacKinnon R, Aldrich RW, Lee AW. Functional stoichiome-try of Shaker potassium channel inactivation. Science 1993; 262:757-9. (Pubitemid 23350698)
20. Pannasch U, Farber K, Nolte C, et al. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. Mol Cell Neurosci 2006;33:401-11. (Pubitemid 44820855)
21. Andersson B, Janson V, Behnam-Motlagh P, Henriksson R, Grankvist K. Induction of apoptosis by intracellular potassium ion depletion: using the f uorescent dye PBFI in a 96-well plate method in cultured lung cancer cells. Toxicol In Vitro 2006;20:986-94.
22. Remillard CV, Yuan JX. Activation of K+ channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol 2004;286:L49-67. (Pubitemid 38055858)
23. Ekhterae D, Platoshyn O, Krick S, Yu Y, McDaniel SS, Yuan JX. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol Cell Physiol 2001;281:C157-65.
24. Ekhterae D, Platoshyn O, Zhang S, Remillard CV, Yuan JX. Apoptosis repressor with caspase domain inhibits cardiomyo-cyte apoptosis by reducing K+ currents. Am J Physiol Cell Physiol 2003;284:C1405-10. (Pubitemid 36583381)
25. Wang Z. Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pf ugers Arch 2004;448:274-86. (Pubitemid 40895596)
26. Wong JY Huggins GS, Debidda M, Munshi NC, De Vivo I. Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol Oncol 2008;109:394-402.
27. MacFarlane SN, Sontheimer H. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the dif erentiation of astrocytes. J Neurosci 2000;20:5245-53. (Pubitemid 30457721)